Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution

International Immunology

Volumn 16, Issue 5, 2004, Pages 635-642

  Li Pira, Giuseppina ^a   Bottone, Laura ^c   Ivaldi, Federico ^a   Pelizzoli, Roberta ^b   Del Galdo, Francesco ^d   Lozzi, Luisa ^e   Bracci, Luisa ^e   Loregian, Arianna ^f   Palù, Giorgio ^f   De Palma, Raffaele ^d   Einsele, Hermann ^g   Manca, Fabrizio ^a  

^a G GASLINI INSTITUTE   (Italy)

^b ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Allodepletion; CD4 cell line; Cellular immunotherapy; Th epitope

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; EPITOPE; PEPTIDE LIBRARY; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PEPTIDE; PHOSPHOPROTEIN;

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOIMMUNITY; AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; CELL CULTURE; CELL LINE; CELL LYSATE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DONOR; DRUG SCREENING; ENZYME LINKED IMMUNOSPOT ASSAY; GOOD MANUFACTURING PRACTICE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY; VIRUS PATHOGENESIS; ADOLESCENT; HELPER CELL; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED;

ADOLESCENT; ADULT; CELL LINE; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PEPTIDE LIBRARY; PEPTIDES; PHOSPHOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL MATRIX PROTEINS;

EID: 2442629552     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh065     Document Type: Article

References (73)

1. Reddehase, M. J., Balthesen, M., Rapp, M., Jonji, S., Pavi, I. and Koszinowski, U. H. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185.
2. Zanghellini, F., Boppana, S. B., Emery, V. C., Griffiths, P. D. and Pass, R. F. 1999. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J. Infect. Dis. 180:702.
3. Griffiths, P. D. and Emery, V. C. 1997. Cytomegalovirus. In Richman, D. D., Whitley, R. J. and Hayden, F. G., eds, Clinical Virology, p. 445. Churchill Livingstone, New York.
4. Hibbert, P. L. and Snydman, D. R. 1995. Cytomegalovirus infection in organ transplant recipients. Infect. Dis. Clin. North Am. 9:863.
5. Meyers, J. D., Flournoy, N. and Thomas, E. D. 1986. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis, 153:478.
6. Li, C. R., Greenberg, P. D., Gilbert, M. J., Goodrich, J. M. and Riddell, S. R. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir. Blood 83:1971.
7. MacGregor, R. R., Pakola, S. J., Graziani, A. L., Montzka, D. P., Hodinka, R. L., Nichols, C. W. and Friedman, H. M. 1995. Evidence of active cytomegalovirus infection in clinically stable HIV-infected individuals, J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:324.
8. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat. Med. 4:953.
9. Polic, B., Hengel, H., Krmpotic, A., Trgovcich, J., Paviæ, I., Lucin, P., Jonjic, S. and Koszinowski, U. H. 1998. Hierarchical and redundant lymphocyte subsets control cytomegalovirus replication during latent infection. J. Exp. Med. 188:1047.
10. Reddehase, M. J., Mutter, W., Munch, K., Bühring, H. J. and Koszinowski, U. H. 1987. CD8 T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61:3102.
11. Riddell, S. R., Reusser, P. and Greenberg, P. D. 1991. Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients. Rev. Infect. Dis. 13:S966.
12. Walter, E. A., Greenberg, P. D., Gilbert, R. J., Watanabe, K. S., Finch, R. J., Watanabe, K. S., Thomas E. D. and Riddell S. R. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor. N. Engl. J. Med, 333:1038.
13. Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E. and Greenberg, P. D. 1992, Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238.
14. Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grogoleit, U., Moris, A. and Rammensee, H. G. 2002. Infusion of cytomegalovirus (CMV) specific T cells for the treatment of CMV infection not responding to chemotherapy. Blood 99:3916.
15. Sun, Q., Pollok, K. E., Burton, R. L., Dai, L. J., Britt, D., Emanuel, D. J. and Lucas, K. G. 1999. Simultaneous ex-vivo expansion of cytomegalovirus and EBV-specific cytotoxic lymphocytes using B-lymphoblastoid cells expressing pp65. Blood 94:3242.
16. Sun, Q., Burton, R. L., Dai, L.J., Britt, W. J. and Lucas, K. G. 2000. B lymphoblastoid cell lines as efficient APC to elicit CD8 responses against cytomegalovirus. J. Immunol. 165:4105.
17. Keever-Taylor, C. A., Margolis, D., Konings, S., Sandford, G. R. and Burns, W. H. 2001. Cytomegalovirus-specific cytolytic T cell lines and clones generated against adenovirus-pp65-infected dendritic cells. Biol. Blood Marrow Transplant 7:247.
18. Szmania, S., Galloway, A., Bruorton, M., Musk, P., Aubert, G., Arthur, A., Pyle, H., Hensel, N., Ta, N., Lamb, L. and Dodi, T. 2001. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes from a single blood draw using dendritic cells and HLA-tetramers. Blood 98:505.
19. + T lymphocytes using dendritic cells pulsed with an A*0201-restricted peptide. Br. J. Haematol. 113:479.
20. Kleihauer, A., Grigolet, U., Hebart, H., Moris, A., Brossart, P., Muhm, A., Stevanovic, S., Rammensee, H. G., Sinzger, C., Riegler S., Jah, G., Kanz, L. and Einsele, H. 2001. Ex vivo generation of human cytomegalovirus specific cytotoxic T cells by peptide-pulsed dendritic cells. Br. J. Haematol. 113:231.
21. + cytomegalovirus pp65 epitope determination. J. Immunol. 167:4196.
22. Peggs, K., Verfuerth, S. and Mackinnon, S. 2001. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen. Blood 97:994.
23. Hebart, H., Daginik, S., Stevanovic, S., Grigoleit, U., Dobler, A., Baur, M., Rauser, G., Sinzger, C., Jahn, G. and Loeffler, J. 2002. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and patients after allogeneic stem cell transplantation. Blood 99:3830.
24. Borysiewicz, L. K., Morris, S., Page, J. D. and Sissons, J. G. P. 1983. Human cytomegalovirus-specific cytotoxic lymphocytes: requirements for in vitro generation and specificity. Eur. J. Immunol. 13:804.
25. Reddehase, M. J. 2002. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2:831.
26. + virus-specific lymphocytes. J. Med. Virol. 43:103.
27. Diamond, D. J., York, J., Sun, J.-Y., Wright, C. L. and Forman, S. J. 1997. Development of a candidate HLA-A*0201 restricted peptide-based vaccine against human cytomegalovirus. Blood 90:1751.
28. Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B. and Sissons, J. G. 1996. The human cytotoxic T-lymphocytes (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency and T-cell receptor usage of pp65-specific CTL. J. Virol. 70:7569.
29. Kondo, E., Akatsuka, Y., Kuzushima, K., Tsujimura, K., Asakura, S., Tajima, K., Kagami, Y., Kodera, Y., Tanimoto, M., Morishima, Y. and Takahashi, T. 2004. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood 103:630.
30. Kern, F., Surel, I. P., Brock, C., Freistedt, B., Radtke, H., Scheffold, A., Blasczyk, R., Reinke, P. and Schneider-Mergener, J. 1998. T-cell epitope mapping by flow cytometry. Nat. Med. 4:975.
31. + epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98:1872.
32. Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Rudawski, I. M., Pruss, A., Gratama, J. W. and Volkmer-Engert, R. 2002. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 85:1709.
33. Weekes, M. P., Wills, M. R., Mynard, K., Carmichael, A. J. and Sissons, J. G. 1999. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 73:2099.
34. Solache, A., Morgan, C. L., Dodi, A. I., Morte, C., Scott, I., Baboonian, C., Zal, B., Goldman, J., Grundy, J. E. and Madrigal, A. 1999. Identification of three HLA-A*0201-restricted cytotoxic epitopes in cytomegalovirus pp65 conserved between eight viral strains. J. Immunol. 163:5512.
35. Borysiewicz, L. K., Hickling, J. K., Graham, S., Sinclair, J., Cranage, M. P., Smith, G. L. and Sissons, J. G. P. 1988. Cytomegalovirus-specific cytotoxic T cells: frequency of stage-specific CTL recognizing the 72KD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med. 168:919.
36. Khan, N., Cobbold, M., Keenan, R. and Moss, P. A. 2002. Comparative analysis of CD8 T cell responses against cytomegalovirus pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality and phenotype. J. Infect Dis. 185:1025.
37. +-T-cell responses to cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73:8179.
38. Frankenberg, N., Pepperl-Klindworth, S., Meyer, R. G. and Plachter, B. 2002. Identification of a conserved HLA-A2-restricted decapeptide from the IE-1 protein (pUL123) of cytomegalovirus. Virology 295:208.
39. Retiere, C., Prod'homme, V., Imbert-Marcille, B. M., Bonneville, M., Vie, H. and Hallet, M. M. 2000. Generation of cytomegalovirus specific human T cell clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE-1 proteins. J. Virol. 74:3948.
40. + T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77:5226.
41. Bonini, C., Lee, S. P., Riddell, S. R. and Greenberg, P. D. 2001. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4 and CD8 T cells. J. Immunol. 166:5250.
42. Carlsson, B., Cheng, W. S., Totterman, T. H. and Essand, M. 2003. Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators. Br. J. Haematol. 121:428.
43. Jonji, S., Mutter, W., Weiland, F., Reddehase, M. J. and Koszinowski, U. H. 1989. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4 lymphocytes. J. Exp. Med. 169:1199.
44. + cytotoxic T-cell responses during chronic viral infection. J Virol. 68:8056.
45. Riddell, S. R. and Greenberg, P. D. 1995. Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13:545.
46. + T cell-mediated control of a herpesvirus in B cell-deficient mice is mediated by IFNgamma. Proc. Natl Acad. Sci. USA 96:5135.
47. June, C. H. 2002. CD4 T cells to kiss off chemotherapy-resistant CMV? Blood 99:3883.
48. Alp, N. J., Allport, T. D., Van Zanten, J., Rodgers, B., Sissons, J. G. and Borysiewicz, L. K. 1991. Fine specificity of cellular immune responses in humans to cytomegalovirus immediate-early I protein. J. Virol. 65:4812.
49. + T cell-clones activated by IE1 peptides. J. Virol. 70:2162.
50. Khattab, B. A., Lindenmaier, W., Frank, R. and Link, H. 1997. Three T-cell epitopes within the C-terminal 265 amino acids of matrix protein pp65 of cytomegalovirus recognized by human lymphocytes. J. Med. Virol. 52:68.
51. + memory T cell response to cytomegalovirus. J. Immunol. 167:1151.
52. van Zanten, J., Harmsen, M. C., van der Meer, P., van der Bij, W., van Son, W. J., van der Giessen, M., Prop, J., de Leij, L. and The, T. H. 1995. Proliferative T cell responses to cytomegalovirus proteins in healthy subjects and solid organ transplant recipients. J. Infect. Dis. 172:879.
53. Manca, F., Habeshaw, J. A. and Dalgleish, A. G. 1991. The naive repertoire of human T cells specific for HIV gp 120. J. Immunol. 146:1964.
54. Manca, F., Fenoglio, D., Li Pira, G., Kunkl, A. and Celada, F. 1991. Effect of antigen-antibody ratio on macrophage processing and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. 173:37.
55. Cresswell, P. 1994. Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
56. Watts, C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:821.
57. Sigal, L. J., Crotty, S., Andino, R. and Rock, K. L. 1999. Cytotoxic T cell immunity to virus infected non haemopoietic cells requires presentation of exogenous antigen. Nature 398:77.
58. + T cells by dendritic cells. J. Virol. 74:10018.
59. Tabi, Z., Moutaftsi, M. and Borysiewicz, L. K. 2001. Human cytomegalovirus pp65 and Immediate Early 1 antigen-specific HLA class I-restricted cytotoxic T cells responses induced by cross-presentation of viral antigens. J. Immunol. 166:5695.
60. Li Pira, G., Bottone, L., Ivaldi, F., Pelizzoli, R., Bracci, L., Lozzi, L., Scarso, L., Tripodi, G. and Manca, F. 2004. Recognition of CMV pp65 protein antigen by human CD4 cell lines induced with an immunodominant peptide pool. Human Immunol. in press.
61. + cells discriminate the molecular context of T epitopes of HIV gp120 and p66. J. AIDS 9:227.
62. Landini, M. P., Guan, M. X., Jahn, G., Lindenmaier, W., Mach, M., Ripalti, A., Necker, A., Lazzarotto, T. and Plachter, B. 1990. Large scale screening of human sera with cytomegalovirus recombinant antigens. J. Med. Microbiol. 28:1375.
63. + lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for CMV infection. Blood 98:1358.
64. Cwynarski, K., Ainsworth, J., Cobbold, M., Wagner, S., Mahendra, P., Apperley, J., Goldman, J., Craddock, C. and Moss, P. A. 2001. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97:1232.
65. Wolf, D. G., Smith, I. L., Lee, D. J., Freeman, W. R., Flores-Aguilar, M. and Spector, S. A. 1995. Mutations in the cytomegalovirus UL97 gene confer resistance to gancyclovir and can be detected in patient plasma. J. Clin. Invest. 95:257.
66. Gamadia, L. E., Remmerswaal, E. B., Weel, J. F., Bemelman, F., van Lier, R. A. and ten Berge, I. J. 2003. Primary immune response to cytomegalovirus: a critical role for IFNg producing CD4 cells in protection against CMV. Blood 101:2686.
67. Vaz-Santiago, J., Lulè, J., Rohrlich, P., Jacquier, C., Gibert, N., Le Roy, E., Betbeder, D., Davignon, J. L. and Davrinche C. 2001. Expansion of CD4 and CD8 cells from peripheral blood mononuclear cells of cytomegalovirus seropositive donors by using a chimeric protein, IE-1-pp65. J. Virol. 75:7840.
68. Kondo, E., Topp, M. S., Kiem, H. P., Obata, Y., Morishima, Y., Kuzushima, K., Tanimoto, M., Harada, M., Takahashi, T. and Akatsuka, Y. 2002. Efficient generation of antigen-specific cytotoxic T cells using retrovirally-transduced CD40-activated B cells. J. Immunol. 169:2154.
69. Hamel, Y., Blake, N., Gabrielsson, S., Haigh, T., Jooss, K., Martinache, C., Caillat-Zucman, S., Rickinson, A. B. and Hacein-Bey, S. 2002. Adenovirally transduced dendritic cells induce bispecific cytotoxic lymphocyte responses against adenovirus and cytomegalovirus-pp65 or against adenovirus and EBV-EBNA3C. Hum. Gene Ther. 13:855.
70. Rammensee, H. G., Bachmann, J., Emmerich, N. P., Bachor, O. A. and Stevanovic, S. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 11:213.
71. Savoldo, B., Cubbage, M. L., Durett, A. G., Goss, J., Huls, M. H., Liu, Z., Teresita, L., Gee, A. P., Ding, P. D. and Brenner, M. K. 2002. Generation of EBV-specific CD4 cytotoxic cells from virus-naive individuals. J. Immunol. 168:909.
72. Manca, F., Li Pira, G., Fenoglio, D., Sun, P., Habeshaw, J. A., Knight, S. and Dalgleish, A. G. 1994. Dendritic cells are potent antigen presenting cells for in vitro induction of primary T cell lines specific for HIV-gp120. J. AIDS 7:15.
73. + T cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity. Blood 85:1547.